Chronic Diarrhea with Villous Blunting of the Small Intestine Under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked Agammaglobulinemia: A Case Series

References

• Arunachalam AK, Maddali M, Aboobacker FN, et al. Primary immunodeficiencies in India: molecular diagnosis and the role of next-generation sequencing. J Clin Immunol. 2021;41(2):393–413. doi:10.1007/s10875-020-00923-2
   PubMed Web of Science ®Google Scholar
• Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union Of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128. doi:10.1007/s10875-017-0464-9
   PubMed Web of Science ®Google Scholar
• Demirdag Y, Fuleihan R, Orange JS, et al. New primary immunodeficiencies 2021 context and future. Curr Opin Pediatr. 2021;33(6):657–675. doi:10.1097/MOP.0000000000001075
   PubMed Web of Science ®Google Scholar
• Bousfiha A, Jeddane L, Picard C, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38(1):129–143. doi:10.1007/s10875-017-0465-8
   PubMed Web of Science ®Google Scholar
• Agarwal S, Cunningham-Rundles C. Gastrointestinal manifestations and complications of primary immunodeficiency disorders. Immunol Allergy Clin North Am. 2019;39(1):81–94. doi:10.1016/j.iac.2018.08.006
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program. 2012;2012(1):301–305. doi:10.1182/asheducation.V2012.1.301.3798316
   PubMedGoogle Scholar
• Pecoraro A, Nappi L, Crescenzi L, et al. Chronic diarrhea in common variable immunodeficiency: a case series and review of the literature. J Clin Immunol. 2018;38(1):67–76. doi:10.1007/s10875-017-0461-z
   PubMed Web of Science ®Google Scholar
• Szczawinska-Poplonyk A, Schwartzmann E, Bukowska-Olech E, et al. The pediatric common variable immunodeficiency - from genetics to therapy: a review. Eur J Pediatr. 2022;181(4):1371–1383. doi:10.1007/s00431-021-04287-6
   PubMed Web of Science ®Google Scholar
• Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) Registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–1770. doi:10.1016/j.jaip.2019.02.004
   PubMed Web of Science ®Google Scholar
• Ameratunga R, Allan C, Woon ST. Defining common variable immunodeficiency disorders in 2020. Immunol Allergy Clin North Am. 2020;40(3):403–420. doi:10.1016/j.iac.2020.03.001
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. Common variable immune deficiency: dissection of the variable. Immunol Rev. 2019;287(1):145–161. doi:10.1111/imr.12728
   PubMed Web of Science ®Google Scholar
• Bogaert DJ, Dullaers M, Lambrecht BN, et al. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J Med Genet. 2016;53(9):575–590. doi:10.1136/jmedgenet-2015-103690
   PubMed Web of Science ®Google Scholar
• Yazdani R, Habibi S, Sharifi L, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. J Investig Allergol Clin Immunol. 2020;30(1):14–34. doi:10.18176/jiaci.0388
   PubMed Web of Science ®Google Scholar
• Park SE, Neaves BI, Adams K. A case of rare splice-site Bruton’s tyrosine kinase mutation with atypical X-linked agammaglobulinemia. Ann Allergy Asthma Immunol. 2022;130(3):364–365. doi:10.1016/j.anai.2022.12.004
   PubMed Web of Science ®Google Scholar
• Cinicola B, Uva A, Leonardi L, et al. Case report: a case of X-linked agammaglobulinemia with high serum IgE levels and allergic rhinitis. Front Immunol. 2020;11:582376. doi:10.3389/fimmu.2020.582376
   PubMed Web of Science ®Google Scholar
• Taneja A, Muco E, Chhabra A. Bruton Agammaglobulinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2023, StatPearls Publishing LLC; 2023.
   Google Scholar
• Ilkjaer FV, Rasmussen LD, Martin-Iguacel R, et al. How to identify common variable immunodeficiency patients earlier: general practice patterns. J Clin Immunol. 2019;39(7):641–652. doi:10.1007/s10875-019-00666-9
   PubMed Web of Science ®Google Scholar
• Dong J, Liang H, Wen D, et al. Adult common variable immunodeficiency. Am J Med Sci. 2016;351(3):239–243. doi:10.1016/j.amjms.2015.12.010
   PubMed Web of Science ®Google Scholar
• Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol. 2013;11(9):1050–1063. doi:10.1016/j.cgh.2013.02.024
   PubMed Web of Science ®Google Scholar
• Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627–632. doi:10.1007/s10875-014-0056-x
   PubMed Web of Science ®Google Scholar
• Barmettler S, Otani IM, Minhas J, et al. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37(3):287–294. doi:10.1007/s10875-017-0374-x
   PubMed Web of Science ®Google Scholar
• Stockman JA. Morbidity and mortality in common variable immune deficiency over 4 decades. Yearbook Pediatr. 2013;2013:321–325. doi:10.1016/j.yped.2012.05.023
   Google Scholar
• Jørgensen SF, Reims HM, Frydenlund D, et al. A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency. Am J Gastroenterol. 2016;111(10):1467–1475. doi:10.1038/ajg.2016.329
   PubMed Web of Science ®Google Scholar
• Fevang B. Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives. Expert Rev Clin Immunol. 2023;19(6):1–12.
   PubMed Web of Science ®Google Scholar
• Parvaneh L, Sharifi N, Azizi G, et al. Infectious etiology of chronic diarrhea in patients with primary immunodeficiency diseases. Eur Ann Allergy Clin Immunol. 2019;51(01):32–37. doi:10.23822/EurAnnACI.1764-1489.77
   PubMedGoogle Scholar
• Song J, Lleo A, Yang GX, et al. Common Variable Immunodeficiency and Liver Involvement. Clin Rev Allergy Immunol. 2018;55(3):340–351. doi:10.1007/s12016-017-8638-z
   PubMed Web of Science ®Google Scholar
• Lackey AE, Ahmad F. X-linked Agammaglobulinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2023, StatPearls Publishing LLC; 2023.
   Google Scholar
• Azizi G, Rezaei N, Kiaee F, et al. T-cell abnormalities in common variable immunodeficiency. J Investigat Allergol Clin Immunol. 2016;26(4):233–243. doi:10.18176/jiaci.0069
   PubMed Web of Science ®Google Scholar
• Andersen IM, Jorgensen SF. Gut inflammation in CVID: causes and consequences. Expert Rev Clin Immunol. 2022;18(1):31–45. doi:10.1080/1744666X.2021.2008241
   PubMed Web of Science ®Google Scholar
• Berbers RM, Nierkens S, van Laar JM, et al. Microbial dysbiosis in common variable immune deficiencies: evidence, causes, and consequences. Trends Immunol. 2017;38(3):206–216. doi:10.1016/j.it.2016.11.008
   PubMed Web of Science ®Google Scholar
• Weber ANR, Bittner Z, Liu X, et al. Bruton’s tyrosine kinase: an emerging key player in innate immunity. Front Immunol. 2017;8:1454. doi:10.3389/fimmu.2017.01454
   PubMed Web of Science ®Google Scholar
• Mao L, Kitani A, Hiejima E, et al. Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1beta-mediated colitis. J Clin Invest. 2020;130(4):1793–1807. doi:10.1172/JCI128322
   PubMed Web of Science ®Google Scholar
• Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59. doi:10.1016/j.jaip.2015.07.025
   PubMed Web of Science ®Google Scholar
• Daniels JA, Lederman HM, Maitra A, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31(12):1800–1812. doi:10.1097/PAS.0b013e3180cab60c
   PubMed Web of Science ®Google Scholar
• Salehzadeh M, Aghamohammadi A, Rezaei N. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy. J Microbiol Immunol Infect. 2010;43(1):11–17. doi:10.1016/S1684-1182(10)60002-3
   PubMedGoogle Scholar
• Cunningham-Rundles C, Maglione PJ. Common variable immunodeficiency. J Allergy Clin Immunol. 2012;129(5):1425–1426.e3. doi:10.1016/j.jaci.2012.03.025
   PubMed Web of Science ®Google Scholar
• Gathmann B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116–126. doi:10.1016/j.jaci.2013.12.1077
   PubMed Web of Science ®Google Scholar
• Malamut G, Verkarre V, Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105(10):2262–2275. doi:10.1038/ajg.2010.214
   PubMed Web of Science ®Google Scholar
• Oksenhendler E, Gérard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46(10):1547–1554. doi:10.1086/587669
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34–48. doi:10.1006/clim.1999.4725
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008;28(Suppl 1):S42–S45. doi:10.1007/s10875-008-9182-7
   PubMed Web of Science ®Google Scholar
• Hajjar J. Common variable immunodeficiency patient fecal microbiota transplant recapitulates gut dysbiosis; 2023.
   Google Scholar
• Çekiç Ş, Özgür T, Karalı Y, et al. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient? Turk J Pediatr. 2019;61(6):937–940. doi:10.24953/turkjped.2019.06.016
   PubMed Web of Science ®Google Scholar
• Johnson D, Lee G, Weber F. Vedolizumab Therapy in Refractory Enteropathy Associated With CVID. ACG Case Rep J. 2022;9(1):e00721. doi:10.14309/crj.0000000000000721
   PubMed Web of Science ®Google Scholar
• Albshesh A, Eder P, Ribaldone DG. Primary hypogammaglobulinaemia with inflammatory bowel disease-like features: an ECCO CONFER multicentre case series. J Crohn’s Colitis. 2022;16(1):91–97. doi:10.1093/ecco-jcc/jjab124
   Google Scholar
• Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369(8):699–710. doi:10.1056/NEJMoa1215734
   PubMed Web of Science ®Google Scholar
• Sifers T, Hirten R, Mehandru S, et al. Vedolizumab therapy in common variable immune deficiency associated enteropathy: a case series. Clin Immunol. 2020;212:108362. doi:10.1016/j.clim.2020.108362
   PubMed Web of Science ®Google Scholar
• Dubinsky MC, Cross RK, Sandborn WJ, et al. Extraintestinal manifestations in vedolizumab and anti-TNF-treated patients with inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(9):1876–1882. doi:10.1093/ibd/izy065
   PubMed Web of Science ®Google Scholar
• Franzblau LE, Fuleihan RL, Cunningham-Rundles C, et al. CVID-associated intestinal disorders in the USIDNET registry: an analysis of disease manifestations, functional status, comorbidities, and treatment. Res Sq. 2023. doi:10.21203/rs.3.rs-2838051/v1
   PubMedGoogle Scholar